The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country

INTRODUCTION: The prognosis of patients with chronic myeloid leukaemia (CML) has improved since the introduction of imatinib. However, patients who do not achieve complete cytogenetic response (CCyR) and major molecular response (MMR) have poorer prognosis. Recent clinical trials have demonstrated t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Singapore Med J
Hlavní autoři: Bee, Ping Chong, Sekaran, Veera, Ng, Richard Rui Jie, Kweh, Ting Yi, Gan, Gin Gin
Médium: Artigo
Jazyk:Inglês
Vydáno: Singapore Medical Association 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5360871/
https://ncbi.nlm.nih.gov/pubmed/27029807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2016063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky